SMURF1 and cancer: An improved understanding of the mechanisms used by SMURF1 to promote MDM2-MDMX heterodimerization at the molecular level can be applied pharmacologically to regulate MDM2 p53 ubiquitylation activity in cancer cells, and therefore serve as a powerful tool to activate pro-apoptotic pathways and interrupt cell division.